Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Maybe It's Not Over

Google AI reports the following:
"Studies have shown that when the FDA advisory committee votes against a drug approval, the FDA still sometimes chooses to approve it, indicating a tendency to favor approval in cases of discordance."
"According to research, when there is a disagreement between the FDA and its advisory committees, the FDA is generally more likely to lean towards approving a drug than its advisors would, meaning the FDA may be more willing to approve a drug even if the advisory committee recommends against it."
"Some factors that might contribute to the FDA leaning towards approval in these cases include pressure from the pharmaceutical industry, the need to provide access to potentially beneficial drugs, or a different interpretation of the data."
I might hold until 12.20.2024.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
6
1
+0
Translate
Report
3100 Views
Comment
Sign in to post a comment
    I do not have any invstmnt experience unless boning a few traders back in the 80s&90s counts. I'm half smart&not greedy
    44Followers
    170Following
    296Visitors
    Follow